Chimeric Therapeutics

Chimeric Therapeutics is a clinical-stage cell therapy company with a focus on discovering, developing and commercialising novel cell therapies with the most curative potential for patients.

Details

Level 3, 62 Lygon Street CARLTON VIC 3053

03 9824 5254

chimerictherapeutics.com

Lists and Charts

Share price

Chimeric Therapeutics

Closing price for the last 90 trading days

View ASX Chart

Total Shareholder Return as at 07/04/26

Rank	Company	1 Yr	5 Yr
1578^th	Evergreen Lithium	-59.98%	0%
1579^th	Butn	-60%	0%
1580^th	Chimeric Therapeutics	-60%	-62.28%
1581^st	Talius Group	-60%	-28.89%
1582^nd	TALI Digital	-60%	-59.34%

View Full List

1678 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Company Share Transactions

Company Activity

	NEW ROLE: Rebecca McQualter,	02 Dec 2024
	NEW ROLE: Phillip Hains, Chief Financial Officer, Joint Company Secretary, Non Executive Director	17 Jul 2024
	NEW ROLE: Eric Sullivan, Non-Executive Director	17 Jul 2024
	NEWS: Tagged in Chimeric drug declares war on deadly pancreatic cancer	23 Nov 2023
	NEWS: Tagged in Chimeric set to flick switch on clinical leukaemia trial	20 Nov 2023
	NEW ROLE: Jason Litten,	06 Nov 2023
	NEWS: Tagged in Chimeric steps up fight against deadliest brain cancer	02 Nov 2023
	NEWS: Tagged in FDA green-lights Chimeric gastrointestinal cancer drug trials	31 Oct 2023
	NEWS: Tagged in Brain cancer survival hopes lifted in Chimeric trials	23 Oct 2023

Related Information

Access to our data for Chimeric Therapeutics is only available to paid subscribers with Data & Insights access.

Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

Chimeric Therapeutics is included in 1 list - Public Companies - non WA.

For public companies, our subscribers have access to the list of executives and directors along with company financials, director's interests and remuneration.

Subscribe today